Stock analysts at StockNews.com began coverage on shares of Senseonics (NYSE:SENS – Get Free Report) in a research note issued to investors on Friday. The firm set a “sell” rating on the stock.
Senseonics Stock Performance
Shares of SENS stock traded down $0.01 on Friday, hitting $0.51. 1,500,591 shares of the company’s stock traded hands, compared to its average volume of 2,443,058. The stock has a market cap of $268.49 million, a PE ratio of -4.60 and a beta of 0.91. The firm’s fifty day moving average is $0.53. Senseonics has a one year low of $0.38 and a one year high of $1.05. The company has a quick ratio of 7.03, a current ratio of 7.53 and a debt-to-equity ratio of 1.15.
Senseonics (NYSE:SENS – Get Free Report) last posted its quarterly earnings results on Thursday, February 29th. The company reported ($0.03) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.01. The business had revenue of $8.00 million during the quarter, compared to analyst estimates of $7.62 million. Senseonics had a negative net margin of 270.13% and a negative return on equity of 146.90%. As a group, sell-side analysts anticipate that Senseonics will post -0.13 earnings per share for the current fiscal year.
Institutional Trading of Senseonics
About Senseonics
Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.
Read More
- Five stocks we like better than Senseonics
- What are earnings reports?
- Appleās Earnings Show Investors Its Strength and Its Weakness
- Why is the Ex-Dividend Date Significant to Investors?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
- 3 Fintech Stocks With Good 2021 Prospects
- DraftKings Q1: Strong Customer Acquisition and Product Innovation
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.